Union Bancaire Privee’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71.4K Hold
600
﹤0.01% 428
2026
Q1
$68.4K Hold
600
﹤0.01% 434
2025
Q4
$61.8K Buy
600
+319
+114% +$41.8K ﹤0.01% 432
2025
Q3
$34.7K Hold
281
﹤0.01% 431
2025
Q2
$33.7K Hold
281
﹤0.01% 433
2025
Q1
$31.6K Hold
281
﹤0.01% 451
2024
Q4
$27.4K Buy
+281
New +$30K ﹤0.01% 514

Other funds holding NVS

Union Bancaire Privee's NVS Position: Q2 2026 in Review

Union Bancaire Privee held its Novartis (NVS) position steady in Q2 2026 at 600 shares worth $71.4K. The position accounts for ﹤0.01% of the portfolio, ranked #428.

Union Bancaire Privee first reported a position in NVS in Q4 2024 and has held it in 7 quarters since. 1,618 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Union Bancaire Privee held 600 shares of Novartis worth $71.4K as of Q2 2026.
  • Union Bancaire Privee left its Novartis share count unchanged in Q2 2026.
  • Novartis made up ﹤0.01% of Union Bancaire Privee's portfolio in Q2 2026, its #428 holding.
  • Union Bancaire Privee first reported a position in Novartis in Q4 2024 and has held it in 7 quarters since.
  • 1,618 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.